Increased Risk of Type 2 Diabetes in Patients With Thyroid Cancer After Thyroidectomy: A Nationwide Cohort Study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Roh, Eun | - |
dc.contributor.author | Noh, Eunjin | - |
dc.contributor.author | Hwang, Soon Young | - |
dc.contributor.author | Kim, Jung A. | - |
dc.contributor.author | Song, Eyun | - |
dc.contributor.author | Park, Minjeong | - |
dc.contributor.author | Choi, Kyung Mook | - |
dc.contributor.author | Baik, Sei Hyun | - |
dc.contributor.author | Cho, Geum Joon | - |
dc.contributor.author | Yoo, Hye Jin | - |
dc.date.accessioned | 2022-04-01T14:40:49Z | - |
dc.date.available | 2022-04-01T14:40:49Z | - |
dc.date.created | 2022-04-01 | - |
dc.date.issued | 2022-02-17 | - |
dc.identifier.issn | 0021-972X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/139372 | - |
dc.description.abstract | Context Abnormal thyroid function after thyroidectomy and subsequent thyroid-stimulating hormone suppression can have detrimental effects on glucose homeostasis in patients with thyroid cancer. Objective To investigate whether thyroidectomy increases the risk of type 2 diabetes in patients with thyroid cancer and to explore the association between levothyroxine dosage and type 2 diabetes risk. Methods A retrospective population-based cohort study using the Korean National Health Insurance database. We included 36 377 thyroid cancer patients without known diabetes who underwent thyroidectomy between 2004 and 2013. Matched subjects with nonthyroid cancer were selected using 1:1 propensity score matching. The main outcome measure was newly developed type 2 diabetes mellitus. Results Patients with thyroid cancer who underwent thyroidectomy had a higher risk of developing type 2 diabetes mellitus than the matched controls (hazard ratio [HR] 1.43, 95% CI 1.39-1.47). Among patients with thyroid cancer, when the second quartile group (in terms of the mean levothyroxine dosage; 101-127 mu g/day) was considered the reference group, the risk of type 2 diabetes mellitus increased in the first quartile (<101 mu g/day; HR 1.45, 95% CI 1.36-1.54) and fourth quartile groups (>= 150 mu g/day; HR 1.37, 95% CI 1.29-1.45); meanwhile, the risk decreased in the third quartile group (128-149 mu g/day; HR 0.91, 95% CI 0.85-0.97). Conclusion Patients with thyroid cancer who underwent thyroidectomy were more likely to develop type 2 diabetes mellitus than the matched controls. There was a U-shaped dose-dependent relationship between the levothyroxine dosage and type 2 diabetes mellitus risk. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ENDOCRINE SOC | - |
dc.subject | THYROTROPIN SUPPRESSION | - |
dc.subject | HEALTH INSURANCE | - |
dc.subject | GRAVES-DISEASE | - |
dc.subject | HORMONE EXCESS | - |
dc.subject | INSULIN ACTION | - |
dc.subject | HYPOTHYROIDISM | - |
dc.subject | MUSCLE | - |
dc.subject | KOREA | - |
dc.subject | ASSOCIATION | - |
dc.subject | THERAPY | - |
dc.title | Increased Risk of Type 2 Diabetes in Patients With Thyroid Cancer After Thyroidectomy: A Nationwide Cohort Study | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Kyung Mook | - |
dc.contributor.affiliatedAuthor | Cho, Geum Joon | - |
dc.identifier.doi | 10.1210/clinem/dgab776 | - |
dc.identifier.scopusid | 2-s2.0-85124850581 | - |
dc.identifier.wosid | 000756897900036 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, v.107, no.3, pp.E1047 - E1056 | - |
dc.relation.isPartOf | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | - |
dc.citation.title | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | - |
dc.citation.volume | 107 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | E1047 | - |
dc.citation.endPage | E1056 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Endocrinology & Metabolism | - |
dc.relation.journalWebOfScienceCategory | Endocrinology & Metabolism | - |
dc.subject.keywordPlus | THYROTROPIN SUPPRESSION | - |
dc.subject.keywordPlus | HEALTH INSURANCE | - |
dc.subject.keywordPlus | GRAVES-DISEASE | - |
dc.subject.keywordPlus | HORMONE EXCESS | - |
dc.subject.keywordPlus | INSULIN ACTION | - |
dc.subject.keywordPlus | HYPOTHYROIDISM | - |
dc.subject.keywordPlus | MUSCLE | - |
dc.subject.keywordPlus | KOREA | - |
dc.subject.keywordPlus | ASSOCIATION | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordAuthor | thyroid cancer | - |
dc.subject.keywordAuthor | thyroidectomy | - |
dc.subject.keywordAuthor | thyroid function | - |
dc.subject.keywordAuthor | type 2 diabetes | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.